By proceeding, you agree to our Terms of Use and Privacy Policy.
Jonas Dyhrfjeld-Johnsen's role at Acousia Therapeutics GmbH is Chief Development Officer & Managing Director
Talks About #Development
Preferred Locations #Europe
There are currently no therapeutics on the market for inner ear disorders, so biotech companies have been paving the way to displace the cochlear implant and cater for the huge unmet need in hearing and balance disorders.